BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

520 related articles for article (PubMed ID: 16553825)

  • 1. Anti-inflammatory activity of cationic peptides: application to the treatment of acne vulgaris.
    Marta Guarna M; Coulson R; Rubinchik E
    FEMS Microbiol Lett; 2006 Apr; 257(1):1-6. PubMed ID: 16553825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peptides with antimicrobial and anti-inflammatory activities that have therapeutic potential for treatment of acne vulgaris.
    Popovic S; Urbán E; Lukic M; Conlon JM
    Peptides; 2012 Apr; 34(2):275-82. PubMed ID: 22374306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nadifloxacin, an antiacne quinolone antimicrobial, inhibits the production of proinflammatory cytokines by human peripheral blood mononuclear cells and normal human keratinocytes.
    Kuwahara K; Kitazawa T; Kitagaki H; Tsukamoto T; Kikuchi M
    J Dermatol Sci; 2005 Apr; 38(1):47-55. PubMed ID: 15795123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathogenesis of acne vulgaris: recent advances.
    Bhambri S; Del Rosso JQ; Bhambri A
    J Drugs Dermatol; 2009 Jul; 8(7):615-8. PubMed ID: 19588637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of Propionibacterium acnes Infection and the Associated Inflammatory Response by the Antimicrobial Peptide P5 in Mice.
    Ryu S; Han HM; Song PI; Armstrong CA; Park Y
    PLoS One; 2015; 10(7):e0132619. PubMed ID: 26197393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cationic antimicrobial peptides and their multifunctional role in the immune system.
    Scott MG; Hancock RE
    Crit Rev Immunol; 2000; 20(5):407-31. PubMed ID: 11145218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. What is the role of antimicrobial peptides (AMP) in acne vulgaris?
    Harder J; Tsuruta D; Murakami M; Kurokawa I
    Exp Dermatol; 2013 Jun; 22(6):386-91. PubMed ID: 23711061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antimicrobial efficacy of granulysin-derived synthetic peptides in acne vulgaris.
    Lim HS; Chun SM; Soung MG; Kim J; Kim SJ
    Int J Dermatol; 2015 Jul; 54(7):853-62. PubMed ID: 25601314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The antimicrobial effect of CEN1HC-Br against Propionibacterium acnes and its therapeutic and anti-inflammatory effects on acne vulgaris.
    Han R; Blencke HM; Cheng H; Li C
    Peptides; 2018 Jan; 99():36-43. PubMed ID: 29108811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acne and sebaceous gland function.
    Zouboulis CC
    Clin Dermatol; 2004; 22(5):360-6. PubMed ID: 15556719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitory effect of the antimicrobial peptide BLP-7 against Propionibacterium acnes and its anti-inflammatory effect on acne vulgaris.
    Wu Y; Qiang Y; Cao K; Zhang W; Zhang G
    Toxicon; 2020 Sep; 184():109-115. PubMed ID: 32540219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The pathogenesis of acne.
    Knor T
    Acta Dermatovenerol Croat; 2005; 13(1):44-9. PubMed ID: 15788147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CBT-SL5, a bacteriocin from Enterococcus faecalis, suppresses the expression of interleukin-8 induced by Propionibacterium acnes in cultured human keratinocytes.
    Lee YJ; Choi HJ; Kang TW; Kim HO; Chung MJ; Park YM
    J Microbiol Biotechnol; 2008 Jul; 18(7):1308-16. PubMed ID: 18667861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Common and alternate oral antibiotic therapies for acne vulgaris: a review.
    Amin K; Riddle CC; Aires DJ; Schweiger ES
    J Drugs Dermatol; 2007 Sep; 6(9):873-80. PubMed ID: 17941358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assay systems for measurement of anti-inflammatory activity.
    Rubinchik E; Pasetka C
    Methods Mol Biol; 2010; 618():349-58. PubMed ID: 20094874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different pro-inflammatory and immunogenic potentials of Propionibacterium acnes and Staphylococcus epidermidis: implications for chronic inflammatory acne.
    Białecka A; Mak M; Biedroń R; Bobek M; Kasprowicz A; Marcinkiewicz J
    Arch Immunol Ther Exp (Warsz); 2005; 53(1):79-85. PubMed ID: 15761379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [General antibiotic therapy in acne].
    Dréno B
    Rev Prat; 2002 Apr; 52(8):841-3. PubMed ID: 12053791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acne: inflammation.
    Farrar MD; Ingham E
    Clin Dermatol; 2004; 22(5):380-4. PubMed ID: 15556722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A review of the anti-inflammatory properties of clindamycin in the treatment of acne vulgaris.
    Del Rosso JQ; Schmidt NF
    Cutis; 2010 Jan; 85(1):15-24. PubMed ID: 20184207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Do we really need topical antibiotics in our new treatment paradigm of acne vulgaris? A novel question to consider based on an updated model of pathogenesis.
    Kircik LH
    J Drugs Dermatol; 2013 Aug; 12(8 Suppl):s107. PubMed ID: 23986174
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 26.